Thursday, December 06, 2012
The IOM and the CIRM Point of View
The California stem cell agency today looked at the study that it paid $700,000 for and decided the glass was half full.
The agency's press release on the 124-page report by the prestigious Institute of Medicine was headlined, “Institute of Medicine Report Praises Stem Cell Agency as a 'Bold Social Innovation.'”
The report also recommended sweeping changes at the agency, including stripping its governing board of the power to approve individual grants, overhauling the board to install a majority of independent directors and fundamentally altering the role of the 10 patient advocates on the 29-member board.